Reinducing Radioiodine-sensitivity in Radioiodine-refractory DTC Using Lenvatinib (RESET)

NCT04858867 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Differentiated Thyroid Cancer

Interventions

RADIATION: rhTSH-stimulated I-124 dosimetry
RADIATION: Intra-therapeutic I-131 dosimetry

Sponsor

Leiden University Medical Center